Respiratory

Latest News

AJMC original research clinical
Health Care Utilization and Cost of Diagnostic Testing for Respiratory Infections

September 17th 2025

Syndromic reverse transcriptase–polymerase chain reaction tests for respiratory infections were associated with lower health care resource utilization and costs, implicating potential for improved value in patient care.

Previous randomized controlled trials have established mepolizumab’s efficacy, but the new study aimed to analyze its performance in a diverse, real-world patient population. | Image credit: luchschenF - stock.adobe.com
Real-World Study Reinforces Mepolizumab's Effectiveness in Severe Eosinophilic Asthma

September 12th 2025

Man holding a cigarette | Image Credit: Nopphon - stock.adobe.com
Rurality, Long Travel Times Limit Access to Tobacco Treatment for Patients With COPD Who Smoke

August 30th 2025

Zopapogene imadenovec, a non-replicating adenoviral vector-based immunotherapy, expresses a fusion antigen made up of selected regions of human papillomavirus (HPV) types 6 and 11 proteins. | Image Credit: aznan - stock.adobe.com
FDA Approves Zopapogene Imadenovec for Recurrent Respiratory Papillomatosis

August 19th 2025

The results showed a significant improvement in patient-reported symptoms at the 12-month follow-up. | Image credit: doucefleur - stock.adobe.com
Biologics Relieve Ear-Related Symptoms Linked With Asthma, CRwNP

August 16th 2025

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo